Demant A/S

Equities

DEMANT

DK0060738599

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:53 2024-05-14 am EDT			5-day change	1st Jan Change
323.2 ^DKK	+0.50%		+0.87%	+9.19%

May. 06	DEMANT : Q1 sales miss; organic growth guidance unchanged
May. 06	Transcript : Demant A/S, Q1 2024 Interim Management Statement Call, May 06, 2024

Demant A/S: Investor news - Demant Kapitalmarkedsdag 2024

November 10, 2023 at 05:23 pm EST

Demant A/S: Investor news - Demant Kapitalmarkedsdag 2024

8.11.2023 09:08:26 CET | Demant A/S | Investor Nyheder

Investor news

8. november 2023

Demant Kapitalmarkedsdag 2024

Demant afholder kapitalmarkedsdag for investorer, analytikere og øvrige aktører fra de finansielle markeder tirsdag den 12. marts 2024 på vores hovedkontor i Smørum.

Sæt kryds i kalenderen, hvis du er interesseret i at deltage i kapitalmarkedsdagen. Yderligere detaljer, herunder information om tilmelding, vil blive udsendt, når vi nærmer os arrangementet.

Yderligere information:

Mathias Holten Møller, Head of Investor Relations

msmo@demant.com

Tlf.: +45 2924 9407

Peter Pudselykke, Investor Relations Officer

pepu@demant.com

Tlf.: +45 2830 7638

Kontakter

Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com

Om Demant A/S

Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people's health and hear-ing. We create life-changing differences through hearing health.

Vedhæftninger

231108 Investor news - Kapitalmarkedsdag 2024.pdf

Vedhæftede filer til pressemeddelelser ritzau-7399-da.pdf
231108 Investor news - Kapitalmarkedsdag 2024.pdf

Attachments

Original Link
Original Document
Permalink

Disclaimer

Demant A/S published this content on 08 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 November 2023 22:22:13 UTC.

Latest news about Demant A/S

DEMANT : Q1 sales miss; organic growth guidance unchanged	May. 06
Transcript : Demant A/S, Q1 2024 Interim Management Statement Call, May 06, 2024	May. 06
Hearing Healthcare Company Demant Affirms FY24 Outlook	May. 06	MT
Demant A/S Provides Earnings Guidance for the Year 2024	May. 06	CI
Denmark's Demant Finalizes Capital Reduction	Apr. 08	MT
Competition Regulator Clears Cochlear’s Acquisition of Oticon Medical’s Cochlear Implant Business	Apr. 03	MT
Demant Seeks Acquisitions	Mar. 12	CI
Transcript : Demant A/S - Analyst/Investor Day	Mar. 12
Nordic Stocks Closed Down Wednesday; Electrolux Series a Posted Biggest Loss	Feb. 28	DJ
Anja Madsen Announces Not to Stand for Re-Election to the Board of Directors of Demant A/S	Feb. 07	CI
Nordic Shares Rose Tuesday; Demant Climbed Highest	Feb. 06	DJ
DEMANT : In-line Q4; markets cheer the promising takeaways for 2024	Feb. 06
Global markets live: BP, Palantir, Infineon, Toyota, UBS...	Feb. 06
Transcript : Demant A/S, 2023 Earnings Call, Feb 06, 2024	Feb. 06
US Futures Mixed, European Stocks Rise as Investors Parse More Fedspeak	Feb. 06	DJ
Tranche Update on Demant A/S's Equity Buyback Plan announced on March 5, 2021.	Feb. 06	CI
Demant A/S Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 06	CI
Demant Forecasts Up to 8% Organic Revenue Growth in FY24	Feb. 06	MT
Demant to Explore Strategic Options for Communications Business Amid Weak Market Conditions	Feb. 05	MT
Demant A/S Provides Earnings Guidance for the Year 2024	Feb. 05	CI
Demant A/S Promotes Peter Pudselykke as Head of Investor Relations Effective 1 March 2024	Jan. 03	CI
Demant to Recommence Share Buybacks	Nov. 21	MT
Nordic Stocks Dropped Tuesday; Demant Took Biggest Hit	Nov. 07	DJ
DEMANT : Sales broadly in-line; guidance narrowed	Nov. 07
Transcript : Demant A/S, Q3 2023 Interim Management Statement Call, Nov 07, 2023	Nov. 07

Chart Demant A/S

Duration

Period

More charts

Company Profile

Demant A/S is the world's 2nd leading producer of audio products. Net sales (excluding activities held for sale) break down by family of products as follows: - tailor-made hearing aids (44.7%): hearing aid and audiphones sold under the Oticon, Bernafon, Philips and Sonic brands; - hearing care products (40.5%): sold in clinics under the brands Audika, HearingLife, Hidden Hearing and Acústica Médica; - diagnostic products (1116%): audiometers sold under the brands Maico, Interacoustics, amplivox, gsi, MedRx and audioscan; - business communication solutions (3.7%). Net sales (excluding activities held for sale) are distributed geographically as follows: Denmark (1.2%), France (9.9%), Europe (29.7%), the United States (34.1%), North America (7%), Asia (10.4%), Pacific (4.9%) and other (2.8%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-21 - Deutsche Bank Conference

Related indices

STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

DEMANT : Q1 sales miss; organic growth guidance unchanged

May 06, 2024 at 11:18 am EDT

More Strategies

Ratings for Demant A/S

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

323.2 DKK

Average target price

332.6 DKK

Spread / Average Target

+2.92%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Prosthetics

	1st Jan change	Capi.
DEMANT A/S	+9.19%	10.13B
STRAUMANN HOLDING AG	-11.50%	21.14B
SONOVA HOLDING AG	+4.15%	17.59B
COCHLEAR LIMITED	+10.91%	14.06B
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.	-11.30%	2.28B
EMBLA MEDICAL HF.	+4.92%	1.8B
ANGELALIGN TECHNOLOGY INC.	+34.04%	1.65B
MODERN DENTAL GROUP LIMITED	+24.42%	652M
ANGEL ROBOTICS CO., LTD.	0.00%	385M
DELCATH SYSTEMS, INC.	+69.95%	150M

Medical Prosthetics